IL17A and metastatic malignant neoplasm in the lymph nodes: Overexpressed in tumour tissues; associated with poor differentiation, lymph node metastasis, vascular invasion, and reduced survival. Promotes proliferation, invasion, and survival. Enhances immune evasion by upregulating PD-L1, TNF, and IL-17.